Medaphor Group PLC Grant of Options (5939P)
May 30 2018 - 2:01AM
UK Regulatory
TIDMMED
RNS Number : 5939P
Medaphor Group PLC
30 May 2018
30 May 2018
MedaPhor Group plc ("the Group" the "Company")
Grant of options
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, announces that the following
additional share options over the Ordinary Shares of the Company
have been granted to the Executive Directors.
Name of Director Position Number of share
options
------------------ ------------------ ----------------
Stuart Gall Chief Executive 2,437,000
------------------ ------------------ ----------------
Chief Technology
Nicholas Sleep Officer 1,605,000
------------------ ------------------ ----------------
Chief Operating
Ian Whittaker Officer 1,000,000
------------------ ------------------ ----------------
Wilson Jennings Finance Director 1,000,000
------------------ ------------------ ----------------
The exercise price of the options is 11.25p per Ordinary
Share.
In respect of each director's share options set out above, one
third of the above share options will vest once the closing
mid-market price of the Company's Ordinary Shares reaches an
average of least 25p per share for a continuous period of 20
business days; one third of the share options will vest once the
closing mid-market price of the Company's Ordinary Shares reaches
an average of at least 37.5p per share for a continuous period of
20 business days and the final third of the share options will vest
once the closing mid-market price of the Company's Ordinary Shares
reaches an average of at least 50p per share for a continuous
period of 20 business days. Any unexercised options will lapse on
29 May 2028.
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075
Ian Whittaker, COO 6534
Cenkos Securities Tel: +44 (0)20 7397
8900
Camilla Hume (Nominated Advisor)
Michael Johnson / Julian
Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or
medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893 / Mob:
Dunphy +44 (0)7876 741 001
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name
Stuart Gall
--- ------------------------- -------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Chief Executive Officer
--- ------------------------- -------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name MedaPhor Group plc
--- ------------------------- -------------------------------
b) LEI N/A
--- ------------------------- -------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description of Ordinary shares of 1p each
the financial
instrument, type
of instrument ISIN: GB00BN791Q39
Identification
code
--- ------------------------- -------------------------------
b) Nature of the Grant of options over ordinary
transaction shares
--- ------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------------
Nil 2,437,000 share
options
--------- ----------------
--- ------------------------- -------------------------------
d) Aggregated information
- Aggregated volume N/A
- Price
--- ------------------------- -------------------------------
e) Date of the transaction 29 May 2018
--- ------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------- -------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name
Nicholas Sleep
--- ------------------------- -------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Chief Technical Officer
--- ------------------------- -------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name MedaPhor Group plc
--- ------------------------- -------------------------------
b) LEI N/A
--- ------------------------- -------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description of Ordinary shares of 1p each
the financial
instrument, type
of instrument ISIN: GB00BN791Q39
Identification
code
--- ------------------------- -------------------------------
b) Nature of the Grant of options over ordinary
transaction shares
--- ------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------------
Nil 1,605,000 share
options
--------- ----------------
--- ------------------------- -------------------------------
d) Aggregated information
- Aggregated volume N/A
- Price
--- ------------------------- -------------------------------
e) Date of the transaction 29 May 2018
--- ------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------- -------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name
Ian Whittaker
--- ------------------------- -------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Chief Operating Officer
--- ------------------------- -------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name MedaPhor Group plc
--- ------------------------- -------------------------------
b) LEI N/A
--- ------------------------- -------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description of Ordinary shares of 1p each
the financial
instrument, type
of instrument ISIN: GB00BN791Q39
Identification
code
--- ------------------------- -------------------------------
b) Nature of the Grant of options over ordinary
transaction shares
--- ------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------------
Nil 1,000,000 share
options
--------- ----------------
--- ------------------------- -------------------------------
d) Aggregated information
- Aggregated volume N/A
- Price
--- ------------------------- -------------------------------
e) Date of the transaction 29 May 2018
--- ------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------- -------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name
Wilson Jennings
--- ------------------------- -------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Finance Director
--- ------------------------- -------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name MedaPhor Group plc
--- ------------------------- -------------------------------
b) LEI N/A
--- ------------------------- -------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description of Ordinary shares of 1p each
the financial
instrument, type
of instrument ISIN: GB00BN791Q39
Identification
code
--- ------------------------- -------------------------------
b) Nature of the Grant of options over ordinary
transaction shares
--- ------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------------
Nil 1,000,000 share
options
--------- ----------------
--- ------------------------- -------------------------------
d) Aggregated information
- Aggregated volume N/A
- Price
--- ------------------------- -------------------------------
e) Date of the transaction 29 May 2018
--- ------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------- -------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLLFERELIAFIT
(END) Dow Jones Newswires
May 30, 2018 02:01 ET (06:01 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024